DUBLIN--(BUSINESS WIRE)--The "Patient Blood Management Market by Product (Instrument (Centrifuge, Transfusion Device, Apheresis, PCR, NGS, Storage Device), Accessories (Syringes, Vials), Reagents, Software)), Component, End User (Blood Bank, Hospital) - Global Forecast to 2024" report has been added to ResearchAndMarkets.com's offering.
The patient blood management market is projected to reach USD 15.3 billion by 2024.
The growth in this market is mainly driven by the rising number of blood donations and blood donors, surge in the prevalence of blood disorders, and rising awareness about blood transfusion safety. However, the high cost of automated instruments is expected to hinder their adoption among end-users during the forecast period.
Blood transfusion segment of instruments to register significant growth due to technological advancements.
The product segment of the patient blood management market is segmented into instruments, accessories, reagents & kits, and software. The instrument segment is further sub-segmented into blood processing devices, blood transfusion devices, blood culture screening devices, diagnostic & testing instruments, and blood storage devices. Technological advancements, new product launches, coupled with the increasing use of autotransfusion systems during critical surgical procedures and organ transplantation, are expected to drive the growth of this segment in the near future.
On the basis of the component, the whole blood segment commanded the leading market share in 2018.
In terms of components, the patient blood management market is segmented into whole blood and blood components. In 2018, the whole blood segment commanded a major share of the market due to the increasing number of blood donors and blood donations across the globe. Moreover, the increasing prevalence of blood disorders such as anaemia and blood cancer that require whole-blood units and RBCs for blood transfusions will further increase the demand for whole blood units, thus contributing to the market growth.
The US patient blood management market to hold a prominent market share during the forecast period.
The patient blood management market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. The US held the major share of the global patient blood management in 2018. Factors such as new product launches and technological advancements in patient blood management products and the presence of key players in this region are driving the growth of this market in the US. Moreover, favorable reimbursement guidelines and high awareness about blood transfusion safety will further fuel market growth.
Key Benefits of Buying the Report
This report focuses on various levels of analysis - industry trends, market shares of top players, and company profiles, which together form basic views. It also analyzes the competitive landscape; and high-growth countries along with their respective drivers, restraints, challenges, and opportunities. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.
Key Topics Covered:
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
2 Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.2 Primary Data
2.2 Market Size Estimation
2.3 Market Breakdown & Data Triangulation
2.4 Assumptions for the Study
3 Executive Summary
4 Premium Insights
4.1 Patient Blood Management Market Overview
4.2 Market, By Product
4.3 Market, By End User
4.4 Market, By Component
4.5 Market, By Region
5 Market Overview
5.2 Market Dynamics
6 Patient Blood Management Market, By Product
6.4 Reagents and Kits
7 Patient Blood Management Market, By Component
7.2 Whole Blood & Red Blood Cells
8 Patient Blood Management Market, By End User
8.2 Blood Banks
8.4 Diagnostic Clinics and & Pathology Labs
9 Patient Blood Management Market, By Region
9.2 North America
9.4 Asia Pacific
9.5 Latin America
9.6 Middle East & Africa
10 Competitive Landscape
10.2 Market Ranking Analysis, 2018
10.3 Competitive Scenario
10.4 Competitive Leadership Mapping (2019)
11 Company Profiles
11.1 Haemonetics Corporation
11.2 Fresenius Se & Co. KGaA
11.3 Terumo Corporation
11.4 Immucor, Inc.
11.5 B. Braun Melsungen AG
11.7 Biomrieux SA
11.8 Asahi Kasei Medical Co. Ltd. (A Subsidiary of Asahi Kasei Corporation)
11.9 Kaneka Corporation
11.10 Bio-Rad Laboratories, Inc.
11.11 Abbott Laboratories
11.12 Grifols, S.A.
11.13 F. Hoffmann-La Roche LTD.
11.14 Livanova PLC
11.15 Danaher Corporation
11.16 Other Companies
11.16.1 Mediware Information Systems
11.16.2 Kawasumi Laboratories, Inc.
11.16.3 Haier Biomedical
11.16.5 Bag Diagnostics GmbH
For more information about this report visit https://www.researchandmarkets.com/r/vvgtqh